Gordon Chan

2.1k total citations
18 papers, 1.6k citations indexed

About

Gordon Chan is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Gordon Chan has authored 18 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Immunology and 5 papers in Genetics. Recurrent topics in Gordon Chan's work include Protein Tyrosine Phosphatases (8 papers), Galectins and Cancer Biology (5 papers) and RNA modifications and cancer (4 papers). Gordon Chan is often cited by papers focused on Protein Tyrosine Phosphatases (8 papers), Galectins and Cancer Biology (5 papers) and RNA modifications and cancer (4 papers). Gordon Chan collaborates with scholars based in United States, Canada and Germany. Gordon Chan's co-authors include Benjamin G. Neel, Demetrios Kalaitzidis, Mariano Barbacid, Kerry Tedford, Jeffery L. Kutok, M. Golam Mohi, Atsuo Ochi, Mark D. Starr, Takehiko Sasaki and Mai P. Nghiem and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Nature Immunology.

In The Last Decade

Gordon Chan

18 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gordon Chan United States 14 1.1k 961 339 176 144 18 1.6k
Raghuveer Singh Mali United States 19 705 0.6× 384 0.4× 149 0.4× 461 2.6× 248 1.7× 44 1.3k
Siqi Lin United States 6 481 0.4× 868 0.9× 100 0.3× 122 0.7× 281 2.0× 11 1.3k
Lisa D. Finkelstein United States 12 323 0.3× 664 0.7× 216 0.6× 91 0.5× 141 1.0× 14 1.0k
Veerendra Munugalavadla United States 20 638 0.6× 480 0.5× 301 0.9× 341 1.9× 411 2.9× 73 1.3k
Yu-Tzu Tai United States 13 1.2k 1.1× 382 0.4× 565 1.7× 632 3.6× 181 1.3× 19 1.8k
Woojoong Lee South Korea 3 1.3k 1.2× 287 0.3× 422 1.2× 476 2.7× 150 1.0× 8 2.0k
Miriam Marqués Spain 19 799 0.7× 279 0.3× 329 1.0× 64 0.4× 117 0.8× 23 1.2k
Morvarid Mohseni United States 15 1.4k 1.2× 255 0.3× 304 0.9× 210 1.2× 113 0.8× 24 2.2k
Que T. Lambert United States 17 1.2k 1.1× 185 0.2× 459 1.4× 136 0.8× 117 0.8× 21 1.6k
Runxiang Zhao United States 24 1.7k 1.5× 334 0.3× 674 2.0× 269 1.5× 493 3.4× 41 2.2k

Countries citing papers authored by Gordon Chan

Since Specialization
Citations

This map shows the geographic impact of Gordon Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon Chan more than expected).

Fields of papers citing papers by Gordon Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon Chan. The network helps show where Gordon Chan may publish in the future.

Co-authorship network of co-authors of Gordon Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon Chan. A scholar is included among the top collaborators of Gordon Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon Chan. Gordon Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Gu, Shengqing, Azin Sayad, Gordon Chan, et al.. (2017). SHP2 is required for BCR-ABL1-induced hematologic neoplasia. Leukemia. 32(1). 203–213. 29 indexed citations
2.
Usenko, Tatiana, Gordon Chan, Emina Torlakovic, Ursula Klingmüller, & Benjamin G. Neel. (2014). Leukemogenic Ptpn11 Allele Causes Defective Erythropoiesis in Mice. PLoS ONE. 9(10). e109682–e109682. 8 indexed citations
3.
Goodwin, Charles B., Xing Jun Li, Raghuveer Singh Mali, et al.. (2014). PI3K p110δ uniquely promotes gain-of-function Shp2-induced GM-CSF hypersensitivity in a model of JMML. Blood. 123(18). 2838–2842. 27 indexed citations
4.
Chan, Gordon, Shengqing Gu, & Benjamin G. Neel. (2013). Erk1 and Erk2 are required for maintenance of hematopoietic stem cells and adult hematopoiesis. Blood. 121(18). 3594–3598. 36 indexed citations
5.
Chan, Gordon, Laurene S. Cheung, Wentian Yang, et al.. (2011). Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells. Blood. 117(16). 4253–4261. 74 indexed citations
6.
Xu, Dan, Siying Wang, Wen-Mei Yu, et al.. (2010). A germline gain-of-function mutation in Ptpn11 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cells. Blood. 116(18). 3611–3621. 58 indexed citations
7.
Huang, Hui, Gordon Chan, Helen He Zhu, et al.. (2010). Tyrosine Phosphorylation of Runx1 In Megakaryocytes by Src Family Kinases. Blood. 116(21). 742–742. 2 indexed citations
8.
Chan, Gordon, Demetrios Kalaitzidis, Tatiana Usenko, et al.. (2009). Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis. Blood. 113(18). 4414–4424. 94 indexed citations
9.
Araki, Toshiyuki, Gordon Chan, Susan Newbigging, et al.. (2009). Noonan syndrome cardiac defects are caused by PTPN11 acting in endocardium to enhance endocardial-mesenchymal transformation. Proceedings of the National Academy of Sciences. 106(12). 4736–4741. 92 indexed citations
10.
Chan, Gordon, Demetrios Kalaitzidis, & Benjamin G. Neel. (2008). The tyrosine phosphatase Shp2 (PTPN11) in cancer. Cancer and Metastasis Reviews. 27(2). 179–192. 305 indexed citations
11.
Chan, Gordon, Demetrios Kalaitzidis, M. Golam Mohi, et al.. (2007). Inducible Expression of Leukemia-Associated Shp2 (Ptpn11) Affects Multiple Stages of Hematopoiesis and Causes a Fatal Myeloproliferative Disorder (MPD) in Mice. Blood. 110(11). 1529–1529. 1 indexed citations
12.
Braun, Benjamin S., Laurene S. Cheung, Gordon Chan, et al.. (2007). A Noncatalytic, Ras-Independent Function of SHP-2 Is Essential in Hematopoietic Progenitors.. Blood. 110(11). 85–85. 2 indexed citations
13.
Mohi, M. Golam, Ifor R. Williams, Charles R. Dearolf, et al.. (2005). Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations. Cancer Cell. 7(2). 179–191. 210 indexed citations
14.
Wei, Jiwu, Sabine Blum, Marcus M. Unger, et al.. (2004). Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lung metastases after intravenous delivery. Cancer Cell. 5(5). 477–488. 87 indexed citations
15.
Chan, Gordon, Thomas Hanke, & Klaus‐Dieter Fischer. (2001). Vav-1 regulates NK T cell development and NK cell cytotoxicity. European Journal of Immunology. 31(8). 2403–2410. 45 indexed citations
16.
Tedford, Kerry, Lars Nitschke, Irutė Girkontaitė, et al.. (2001). Compensation between Vav-1 and Vav-2 in B cell development and antigen receptor signaling. Nature Immunology. 2(6). 548–555. 145 indexed citations
17.
Kong, Young‐Yun, Hiroshi Nishina, Kerry Tedford, et al.. (1998). Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor. Current Biology. 8(10). 554–S3. 380 indexed citations
18.
Chan, Gordon & Atsuo Ochi. (1995). Sphingomyelin‐ceramide turnover in CD28 costimulatory signaling. European Journal of Immunology. 25(7). 1999–2004. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026